Liu, J. et al. 2022. Effects of glucagon-like peptide-1 receptor agonists (GLP-1RAs) on podocytes, inflammation, and oxidative stress in patients with diabetic nephropathy (DN). Pakistan Journal of Medical Sciences. 38, 5 (May 2022). DOI:https://doi.org/10.12669/pjms.38.5.4719.